ISG Launches Study on Rapidly Growing SDN Market
STAMFORD, Conn., Feb. 07, 2020 (GLOBE NEWSWIRE) — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and […]
Tonix Pharmaceuticals Prices $7.5 million Public Offering
NEW YORK, Feb. 07, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage […]
Salarius Announces Pricing of $9.6 Million Underwritten Public Offering
HOUSTON, Feb. 07, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes […]
Diffusion Pharmaceuticals Receives European Patent Related Compositions of TSC
CHARLOTTESVILLE, Va., Feb. 07, 2020 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology […]
Aurora Spine Announces Closing of Private Placement Financing
CARLSBAD, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE:ASG) is pleased […]
Nathan’s Famous, Inc. Reports Third Quarter Results
JERICHO, N.Y., Feb. 07, 2020 (GLOBE NEWSWIRE) — Nathan’s Famous, Inc. (NASDAQ:NATH) today reported results for the third quarter of […]
EXL Achieves Leader and Star Performer Status in Everest Group PEAK Matrix® Assessment 2019 for Life and Pensions Insurance BPO Services
NEW YORK, Feb. 07, 2020 (GLOBE NEWSWIRE) — EXL (NASDAQ: EXLS), a leading Operations Management and Analytics company, today announced […]
BOQI International Medical Amends Terms for Acquisition of Boqi Zhengji Pharmacy Chain
New York, Feb. 07, 2020 (GLOBE NEWSWIRE) — BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced […]
Beyond Air Reports Financial Results for Fiscal Third Quarter 2020
LungFit™ PH U.S. market launch for the treatment of persistent pulmonary hypertension of the newborn (PPHN) expected calendar 4Q 2020Third […]
TRACON Pharmaceuticals Announces Change to Nasdaq Capital Market
SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]
